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Organic chemistry can contribute to the innovation 
through the design and synthesis of molecules those are 
valuable to human society. Our methodology possesses 
advantage in heteroatom chemistry, transition metal-
catalyzed reactions, and asymmetric synthesis. As for the 
synthetic procedure, we take note to develop atom-
economic as well as environment-benign reactions. We 
recognize the importance of the collaboration with various 
fields of technology of industry and academia. Recent 
examples of our projects include design, synthesis, and 
evaluation of aromatic compounds used in light-emitting 
field-effect transistors, sugar-fullerene linked compounds 
used in photodynamic therapy of cancers, and gadolinium 
complex of chiral dendrimers used in magnetic resonance 
imaging of cancers (shown in the figure).
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Size-controlled and Biocompatible Gd2O3 
Nanoparticles for Dual Photoacoustic and 
MR Imaging
One of the most rapidly developing and exciting applica-
tions of nanotechnology in biomedical research is the devel-
opment of biocompatible nanoparticles for use in multiple, 
powerful and highly complementary imaging modalities. Our 
main goal is to synthesize and isolate new size-controlled and 
biocompatible Gd2O3 nanoparticles as an unconjugated bimodal 
contrast agent for use in photoacoustic tomography (PAT) 
and magnetic resonance (MR) imaging through the fusion of 
inorganic nanoparticles and organic peptide coating.
Gd2O3 nanoparticles used in this study were obtained by 
applying a previously reported protocol for the alkaline hy-
drolysis of Gd(NO3)3 carried out in diethylene glycol 
(DEG) at 180°C. To isolate the DEG-coated Gd2O3 
nanoparticles, this reaction mixture was further added to 
pure acetone to give dark brown precipitates. After the pre-
cipitates were dried under vacuum and dispersed in pure 
water, a dynamic light scattering (DLS) measurement of the 
isolated Gd2O3-DEG nanoparticles gave a sharp and repro-
ducible peak at 100 nm during an appropriate time-window.
However, the mean size (hydrodynamic diameter) of 
the isolated Gd2O3-DEG nanoparticles increased greatly 
over time in pure water, which is a sign of coarse aggrega-
tion. We found that the surface modification of Gd2O3-
DEG nanoparticles with biocompatible gelatin could be 
used to maintain a constant diameter even after 45 h. In 
addition, the size (diameter) of the new nanoparticles 
could be completely controlled (20–200 nm) by timing the 
addition of an aqueous solution of gelatin to the suspen-
sion of Gd2O3-DEG nanoparticles in pure water.
A transmission electron microscopy (TEM) of the new 
nanoparticles of a hydrodynamic diameter of 100 nm 
showed that the thickness of the outer layer is 10–30 nm 
and Gd2O3-DEG nanoparticles were observed as small 
dots (5 nm; indicated with white circles) (Figure 1). Based 
on the process of synthesis, it is conceivable that the outer 
layer of new nanoparticles consists of gelatin (indicated 
with black arrowheads), and the inner small dots should 
be unconjugated Gd2O3 because of its high electron densi-
ty. The remaining space in the nanoparticles was filled by 
DEG (indicated with white arrowheads).
Figure 2 shows a photoacoustic (PA) image of mice be-
fore and after subcutaneous injection of the new nanopar-
ticles. After the injection, the intense signal was observed 
at the injected area. These signals were expected to be 
emitted from Gd2O3 nanoparticles and no PA signals for 
DEG or gelatin were observed.
The MRI study clearly showed that the new nanoparti-
cles are a T1-positive MRI contrast agent, and their relax-
ivity r1 is twice that of clinically available Gd-DETA. 
Since the relaxivity r1 strongly depends on the rotational 
dynamics of molecules with a magnetic moment, the rota-
tion of new nanoparticles could be inhibited by their grav-
ity, which results in an increase in sensitivity as well as 
reduction in dose.
MR images of a whole mouse clearly showed that the 
new nanoparticles freely circulate in the blood vessels with-
out undesirable accumulation in the lungs (Figure 3). We 
consider that these new nanoparticles could be useful as a 
contrast agent for angiography. In addition, signals in the 
liver were diminished, while signals in the colon were ob-
served on MR imaging 24 h after injection (Figure 3b). In 
addition, we have confirmed that the mice 72 h after intra-
venous injection of the present nanoparticles were alive, 
and MR intensity of the liver decreased. Thus, we consider 
that the nanoparticles after the injection could be eliminated 
from the liver through the bile duct without any chemical 
alteration, such as generation of a free Gd3+ ion and the ac-
cumulation as GdPO4 microcrystals in the liver.
Figure 1. Transmission electron 
 microscopy (TEM) of Gd2O3-DEG-
gelatin nanoparticles (scale-bar; 100 
nm).
Figure 2. Photoacoustic (PA) images of mice (a) before and (b) after 
 subcutaneous injection of Gd2O3-DEG-gelatin nanoparticles.
(a) (b)
Figure 3. T1-weighted magnetic 
 resonance (MR) images of mice (a) 
5 min and (b) 24 h after intravenous 
 injection of Gd2O3-DEG-gelatin 
nanoparticles (0.10 mmol Gd/kg).
(a) (b)
